EverSource Wealth Advisors’s Editas Medicine EDIT Stock Holding History

EverSource Wealth Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.35K	Sell	1,342 -738	-35%	-$2.16K	﹤0.01%	3355
2026 Q1	$5.14K	Buy	2,080 +1,654	+388%	+$3.5K	﹤0.01%	3260
2025 Q4	$873	Sell	426 -21	-5%	-$61	﹤0.01%	3742
2025 Q3	$1.55K	Hold	447	–	–	﹤0.01%	3604
2025 Q2	$983	Buy	447 +1	+0.2%	+$2	﹤0.01%	3742
2025 Q1	$517	Sell	446 -93	-17%	-$137	﹤0.01%	3449
2024 Q4	$685	Buy	+539	New	+$1.37K	﹤0.01%	3089

Other funds holding EDIT

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

JIC

Joel Isaacson & Co New York $3.45B AUM 27.72% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

TWM

Thrive Wealth Management Audubon, Pennsylvania $787M AUM 23.6% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

EverSource Wealth Advisors's EDIT Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Editas Medicine (EDIT) stake by 35% in Q2 2026, selling an estimated $2.16K and leaving 1,342 shares worth $4.35K. The position accounts for ﹤0.01% of the portfolio, ranked #3355.

EverSource Wealth Advisors first reported a position in EDIT in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.14K in Q1 2026. 56 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

EverSource Wealth Advisors held 1,342 shares of Editas Medicine worth $4.35K as of Q2 2026.
EverSource Wealth Advisors sold 738 Editas Medicine shares in Q2 2026, an estimated $2.16K.
Editas Medicine made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3355 holding.
EverSource Wealth Advisors first reported a position in Editas Medicine in Q4 2024 and has held it in 7 quarters since.
EverSource Wealth Advisors's Editas Medicine position peaked at $5.14K in Q1 2026.
56 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.